Private: QOF Disease Prevalence
Tiered pricing
Asthma is a highly prevalent condition and 85% of people with asthma are solely managed by primary care. Asthma can be treated effectively with appropriate management and patients achieving good control of their condition.
The NHS spends around £1.1 billion a year treating and caring for people with asthma and dedicates considerable resource to the management of asthma in a primary care setting to minimise the
morbidity and mortality associated with poorly controlled asthma.
Interface partner with healthcare organisations to, including practices, PCNs and ICSs to deliver a proactive risk management approach to asthma to improve outcomes and reduce urgent care episodes.
Get in touch to discuss Asthma Therapy further or apply here directly
Need some help? Get in touch
Interface are able to support the systematic management of adults with asthma in line with best practice guidelines to improve patient outcomes.
Using your practice clinical system and our bespoke searches, Interface can:
Our pharmacists will review adults with indicators of uncontrolled asthma to help optimise the management of their condition. Interface can also review adults currently prescribed moderate/high-dose inhaled corticosteroids who are well controlled. It may be the case that their treatment plans can be stepped down benefiting both the patient and practice.
Tiered pricing
Our Clinical Pharmacists are now able to offer coding support across a number of QOF domains